» Authors » Hassan Fahmi

Hassan Fahmi

Explore the profile of Hassan Fahmi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 89
Citations 3173
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Buyl K, Merimi M, Rodrigues R, Rahmani S, Fayyad-Kazan M, Bouhtit F, et al.
Biomolecules . 2024 Jul; 14(7). PMID: 39062566
Background: AT-MSCs display great immunoregulatory features, making them potential candidates for cell-based therapy. This study aimed to evaluate the "RBC lysis buffer" isolation protocol and immunological profiling of the so-obtained...
2.
Kariminezhad Z, Rahimi M, Fernandes J, Maltais R, Sanceau J, Poirier D, et al.
Antioxidants (Basel) . 2024 Apr; 13(4). PMID: 38671833
In osteoarthritis (OA), oxidative stress plays a crucial role in maintaining and sustaining cartilage degradation. Current OA management requires a combination of pharmaceutical and non-pharmacological strategies, including intraarticular injections of...
3.
Najar M, Rahmani S, Faour W, Alsabri S, Lombard C, Fayyad-Kazan H, et al.
Cells . 2024 Jan; 13(2). PMID: 38247860
As a form of immunomodulatory therapeutics, mesenchymal stromal/stem cells (MSCs) from umbilical cord (UC) tissue were assessed for their dynamic interplay with the Th-17 immune response pathway. UC-MSCs were able...
4.
Najar M, Alsabri S, Guedi G, Merimi M, Lavoie F, Grabs D, et al.
Front Cell Dev Biol . 2023 Dec; 11:1256998. PMID: 38099292
D prostanoid receptor 1 (DP1), a prostaglandin D2 receptor, plays a central role in the modulation of inflammation and cartilage metabolism. We have previously shown that activation of DP1 signaling...
5.
Alsabri S, Guedi G, Najar M, Merimi M, Lavoie F, Grabs D, et al.
Inflamm Res . 2023 Oct; 72(12):2145-2153. PMID: 37874359
Objective And Design: 15-Lipoxygenase-1 (15-LOX-1) catalyzes the biosynthesis of many anti-inflammatory and immunomodulatory lipid mediators and was reported to have protective properties in several inflammatory conditions, including osteoarthritis (OA). This...
6.
Najar M, Fahmi H, Merimi M
Biomolecules . 2023 Aug; 13(8). PMID: 37627236
Cancer is a highly lethal disease that causes millions of deaths worldwide, thus representing a major public health challenge [...].
7.
Merimi M, Fahmi H, Kock J, Beguin C, Burny A, Moll G, et al.
Cells . 2022 Oct; 11(19). PMID: 36231120
We are pleased to present this opening editorial, introducing our topical collection, "The New Era of Mesenchymal Stromal/Stem Cell Functional Application: State of the Art, Therapeutic Challenges and Future Directions"...
8.
Merimi M, Rahmani S, Afailal Tribak A, Bouhtit F, Fahmi H, Najar M
Cells . 2022 Jun; 11(12). PMID: 35741105
We are pleased to present this Special Issue of , entitled 'Feature Papers in Stem Cells' [...].
9.
Tardif G, Pare F, Gotti C, Roux-Dalvai F, Droit A, Zhai G, et al.
Arthritis Res Ther . 2022 May; 24(1):120. PMID: 35606786
Background: Osteoarthritis (OA) is a slowly developing and debilitating disease, and there are no validated specific biomarkers for its early detection. To improve therapeutic approaches, identification of specific molecules/biomarkers enabling...
10.
Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Moussa Agha D, et al.
Front Cell Dev Biol . 2022 Jan; 9:716853. PMID: 35096805
Cellular therapy aims to replace damaged resident cells by restoring cellular and molecular environments suitable for tissue repair and regeneration. Among several candidates, mesenchymal stem/stromal cells (MSCs) represent a critical...